What's Going On With Aclarion Stock Tuesday?
What's Going On With Aclarion Stock Tuesday?
Chief Strategy Officer Aclarion, Inc. (NASDAQ:ACON) stock is trading higher on Tuesday after the company announced it secured funding for its CLARITY trial of its diagnostic tool, Nociscan.
Aclarion, Inc.（纳斯达克股票代码：ACON）周二股价走高，此前该公司宣布已为其诊断工具Nociscan的CLARITY试验获得了资金。
What To Know: The company has raised approximately $20 million in gross proceeds since the start of 2025, which will fully fund the clinical trial. The trial aims to test Nociscan's ability to improve surgical outcomes for chronic low back pain patients.
须知：自2025年初以来，该公司已筹集了约2000万美元的总收益，这将为临床试验提供全额资金。该试验旨在测试Nociscan改善慢性腰痛患者手术结果的能力。
The trial will enroll 300 patients across multiple sites and build on peer-reviewed data, demonstrating Nociscan's ability to improve surgical outcomes by helping surgeons target the specific discs identified by the tool as the source of pain.
该试验将招收来自多个地点的300名患者，并以同行评审的数据为基础，证明Nociscan有能力通过帮助外科医生靶向该工具确定为疼痛源的特定椎间盘来改善手术结果。
Chief Strategy Officer Ryan Bond stated, "This milestone ensures we reach the study's conclusion, potentially unlocking broad payer coverage and redefining chronic low back pain treatment."
首席战略官瑞安·邦德表示：“这一里程碑确保了我们得出研究结论，有可能开启广泛的付款人保障，并重新定义慢性腰痛的治疗方法。”
Related Link: Behind the Scenes of Meta Platforms's Latest Options Trends
相关链接：元平台最新期权趋势的幕后花絮
ACON Price Action: At the time of writing, Aclarion shares are trading 6.02% higher at $7.05, according to data from Benzinga Pro.
ACON价格走势：根据Benzinga Pro的数据，在撰写本文时，Aclarion股价上涨6.02％，至7.05美元。
Image: via Shutterstock
图片：通过 Shutterstock
随着电子商务和云计算服务商的发展， $亚马逊 (AMZN.US)$ 引起了广泛的市场关注。 它将于1月30日收盘后公布其 2月6日的上一季度收益报告。
解锁见解， 亚马逊收益中心>>
奖励
● 5000点积分的均等份额： 对于猜测正确的mooer们 在日内交易中获得最大百分比收益的赢家 在他们发布收益的第一天 （例如，如果50个mooer们......
评论(0)
请选择举报原因